1,909 followers
RT @Brandon_Beaber: This open-label observational study on tysabri (natalizumab) in 20 children with multiple sclerosis (mean age 13.8) fin…
438 followers
RT @Brandon_Beaber: This open-label observational study on tysabri (natalizumab) in 20 children with multiple sclerosis (mean age 13.8) fin…
192 followers
RT @Brandon_Beaber: This open-label observational study on tysabri (natalizumab) in 20 children with multiple sclerosis (mean age 13.8) fin…
2,802 followers
RT @Brandon_Beaber: This open-label observational study on tysabri (natalizumab) in 20 children with multiple sclerosis (mean age 13.8) fin…
1,279 followers
RT @Brandon_Beaber: This open-label observational study on tysabri (natalizumab) in 20 children with multiple sclerosis (mean age 13.8) fin…
16,101 followers
This open-label observational study on tysabri (natalizumab) in 20 children with multiple sclerosis (mean age 13.8) finds that it is very effective with no evidence of disease activity (NEDA-3) in 16/20 (80%) after a mean of 42 infusions. https://t.co/EAad
1,158 followers
RT @Brandon_Beaber: In this small cohort of 20 children with multiple sclerosis treated with natalizumab (Tysabri), 80% achieved "no eviden…
434 followers
RT @Brandon_Beaber: In this small cohort of 20 children with multiple sclerosis treated with natalizumab (Tysabri), 80% achieved "no eviden…
2,023 followers
RT @Brandon_Beaber: In this small cohort of 20 children with multiple sclerosis treated with natalizumab (Tysabri), 80% achieved "no eviden…
2,097 followers
RT @Brandon_Beaber: In this small cohort of 20 children with multiple sclerosis treated with natalizumab (Tysabri), 80% achieved "no eviden…
658 followers
RT @Brandon_Beaber: In this small cohort of 20 children with multiple sclerosis treated with natalizumab (Tysabri), 80% achieved "no eviden…
1,909 followers
RT @Brandon_Beaber: In this small cohort of 20 children with multiple sclerosis treated with natalizumab (Tysabri), 80% achieved "no eviden…
436 followers
RT @Brandon_Beaber: In this small cohort of 20 children with multiple sclerosis treated with natalizumab (Tysabri), 80% achieved "no eviden…
4,102 followers
RT @Brandon_Beaber: In this small cohort of 20 children with multiple sclerosis treated with natalizumab (Tysabri), 80% achieved "no eviden…
1,787 followers
RT @Brandon_Beaber: In this small cohort of 20 children with multiple sclerosis treated with natalizumab (Tysabri), 80% achieved "no eviden…
834 followers
RT @Brandon_Beaber: In this small cohort of 20 children with multiple sclerosis treated with natalizumab (Tysabri), 80% achieved "no eviden…
16,101 followers
In this small cohort of 20 children with multiple sclerosis treated with natalizumab (Tysabri), 80% achieved "no evidence disease activity" over 2 years, and the group had less disability by the end of the study without major side effects. https://t.co/EAa
113 followers
RT @ingentium_ms: No evidence of disease activity including #cognition (NEDA-3 plus) in naïve pediatric #MultipleSclerosis #MS patients tre…
602 followers
No evidence of disease activity including #cognition (NEDA-3 plus) in naïve pediatric #MultipleSclerosis #MS patients treated with natalizumab. https://t.co/GkMnmJgfEJ